Aclaris Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $9,211 | $4,346 | $2,766 | $2,398 |
Gross Profit | -90 | 1,938 | 857 | 558 |
EBITDA | -13,927 | -9,492 | -12,612 | -15,988 |
EBIT | -14,070 | -9,671 | -12,812 | -16,231 |
Net Income | -96,552 | -7,586 | -10,986 | -16,941 |
Net Change In Cash | 9,211 | 4,346 | 2,766 | 2,398 |
Free Cash Flow | -44,748 | 22,000 | -12,308 | -20,950 |
Cash | 24,570 | 47,651 | 22,834 | 35,841 |
Basic Shares | 77,296 | 71,381 | 71,291 | 71,074 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $18,720 | $31,249 | $29,752 | $6,761 |
Gross Profit | 15,928 | 13,168 | 17,792 | 2,048 |
EBITDA | -51,720 | -117,565 | -84,357 | -65,060 |
EBIT | -52,527 | -118,428 | -85,154 | -65,983 |
Net Income | -132,065 | -88,481 | -88,662 | -114,281 |
Net Change In Cash | 18,720 | 31,249 | 29,752 | 6,761 |
Cost of Revenue | 17,928 | 5,286 | ||
Free Cash Flow | -20,196 | -79,634 | -68,172 | -52,442 |
Cash | 24,570 | 39,878 | 45,277 | 27,349 |
Basic Shares | 77,296 | 69,808 | 65,213 | 56,730 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$1.01 |
2024-09-30 | -$0.11 |
2024-06-30 | -$0.15 |
2024-03-31 | -$0.24 |
